289677-10-7 Usage
General Description
(R)-4-Benzyl-3-(3-cyclopentyl-propionyl)-oxazolidin-2-one is a chemical compound that belongs to the class of oxazolidinone derivatives. It exists as a white crystalline solid and is used as a starting material in organic synthesis. (R)-4-BENZYL-3-(3-CYCLOPENTYL-PROPIONYL)-OXAZOLIDIN-2-ONE has potential applications in pharmaceuticals and materials science due to its unique structural and chemical properties. It is known for its ability to act as a chiral building block in the synthesis of various biologically active molecules and has been studied for its potential pharmacological activities. Additionally, its cyclopentyl and benzyl groups contribute to its stereochemistry and functional properties. Overall, (R)-4-benzyl-3-(3-cyclopentyl-propionyl)-oxazolidin-2-one is a versatile chemical compound with potential applications in various scientific and industrial fields.
Check Digit Verification of cas no
The CAS Registry Mumber 289677-10-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,9,6,7 and 7 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 289677-10:
(8*2)+(7*8)+(6*9)+(5*6)+(4*7)+(3*7)+(2*1)+(1*0)=207
207 % 10 = 7
So 289677-10-7 is a valid CAS Registry Number.
InChI:InChI=1/C18H23NO3/c20-17(11-10-14-6-4-5-7-14)19-16(13-22-18(19)21)12-15-8-2-1-3-9-15/h1-3,8-9,14,16H,4-7,10-13H2/t16-/m1/s1
289677-10-7Relevant articles and documents
Hydroxyalkanoylaminolactams and related structures as inhibitors of A-beta protein production
-
, (2008/06/13)
This invention relates to novel lactams having the formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of A
Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production
-
, (2008/06/13)
This invention relates to novel lactams having the formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of A